TORONTO --
Growing evidence about the powers of psilocybin, a naturally occurring
psychedelic compound produced by several species of mushrooms, being
used to treat anxiety and depression has inspired advocates to file a
federal court challenge next month to allow its use to treat terminally
ill patients.Psychotherapist and professor at the University of Victoria Bruce Tobin has been on the forefront of those advocating to end the prohibition of the drug – highlighting its potential for cancer patients …